The Chamber of Commerce has asked for a preliminary injunction to halt the program before Oct. 1, the deadline for pharma companies to agree to Medicare negotiations on pricing for the first 10 drugs.
https://www.pharmalive.com/wp-content/uploads/2023/09/New-York-Chamber-of-Commerce.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-09-18 09:27:002023-09-18 09:28:50DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiation Program
